GlassScriptPhysician profile
Amy L Long
NPI 1689813453
$2,156.03
in general payments reported to CMS, 2019-2025
27 companies · $482 in 2025
The $482 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $87.88 · 2021: $253 · 2022: $181 · 2023: $286 · 2024: $404 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $284.74 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $261.93 | 2021-2025 | Thinprep 2000 Processor, Aptima |
| Exeltis, USA INC. | $236.57 | 2019-2025 | Slynd |
| Abbvie INC. | $226.84 | 2019-2022 | |
| Gynesonics, INC. | $157.79 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mayne Pharma Commercial LLC | $156.02 | 2022-2025 | |
| Sage Therapeutics, LLC | $111.64 | 2019-2025 | Zurzuvae |
| Organon LLC | $100.74 | 2022-2025 | Nexplanon |
| Abbott Laboratories | $94.54 | 2019 | |
| Shield Therapeutics INC | $74.01 | 2023-2025 | Accrufer |
| Pfizer INC. | $67.54 | 2019-2025 | |
| Therapeuticsmd, INC. | $39.95 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.87 | 2020-2025 | |
| Amag Pharmaceuticals, INC. | $36.22 | 2019 | |
| Heron Therapeutics, INC. | $34.33 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $29.50 | 2023 | Gardasil 9 |
| Meditrina | $27.46 | 2023-2024 | |
| Allergan, INC. | $25.73 | 2019 | |
| Sumitomo Pharma America, INC. | $21.73 | 2024 | Myfembree |
| Optumhealth Care Solutions, LLC | $20.78 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Mylan Pharmaceuticals INC. | $20.77 | 2022 | |
| Lupin INC. | $16.52 | 2019 | |
| Duchesnay USA Incorporated | $15.60 | 2020 | |
| Baxter Healthcare | $15.41 | 2019 | |
| Minerva Surgical, INC | $15.10 | 2023 | |
| Novo Nordisk INC | $13.75 | 2023 | Wegovy |
| Coopersurgical, INC. | $12.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.